Key facts
- MoonRise Health’s last known valuation is $8.0M (Oct 2020).
- It has raised $820K; the latest was Later Stage VC in Jan 2026.
- Notable investors include Angel Invest, Calm/Storm Ventures, Adele Treschownrise, Anastasia Georgiadou, Andrej Steinberg — 18 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for MoonRise Health
- ·The full record, as it builds
Funding rounds
No funding rounds for MoonRise Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MoonRise Health
Developer of a holistic pelvic-health program platform designed to help women naturally address leaks, pain, heaviness, and related pelvic floor concerns. The company's platform offers expert-led guidance, personalized coaching, gentle whole-body methods, and community support, enabling women seeking non-surgical and non-Kegel approaches to restore pelvic function, ease discomfort, and reconnect with their bodies.
- Sector
- Healthcare
- HQ
- Lidingo, Sweden
- Founded
- 2020
- Employees
- 8
- Website
- moonrise.health/
- Ownership
- Privately Held (backing)
MoonRise Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MoonRise Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MoonRise Health in its N-PORT filings yet. We sweep new filings monthly.